8 drug delivery innovations you need to know

The drug delivery space has seen plenty of innovation over the years and there are no signs of that slowing down any time soon.

Improvements upon established technologies like insulin delivery devices and inhalers have been presented by some, while others have unlocked new ways of delivering drugs through a variety of means.

Among the best innovations in the space are some of the heavy-hitting companies, like Medtronic and Tandem Diabetes Care. Some up-and-comers are beginning to make waves, too, while research continues to uncover new ways to deliver therapeutics.

Here are eight types of drug delivery innovations you should know:

Read more
  • 0

Dyve Biosciences appoints Camilla V. Simpson to its board

Clinical-stage biotechnology company Dyve Biosciences announced this week that Camilla V. Simpson joined its board of directors.

Simpson possesses over 25 years of experience in the biotech industry, currently serving as an independent member of the board of directors at Spruce Biosciences and as a member of the scientific advisory board at Aristea Therapeutics, according to a news release.

She also holds the role of president of Rare Strategic and acts as a strategic advisor to early-stage biotech companies working in a number of indications across various modalities.

Simpson has also held previous roles including senior VP & head of product portfolio development at BioMarin Pharmaceutical and, before that, she was the VP of global regulatory strategy for early development and business development at Shire Pharmaceuticals.

“I am very pleased to join Dyve’s board of directors to support its efforts to develop new therapeutics utilizing innovat…

Read more
  • 0